Press releases
- Geron Corporation Announces Chief Commercial Officer to Depart at End of August 2024
- Geron to Announce Second Quarter 2024 Financial Results on August 8, 2024
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia
- Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights
- Geron to Announce First Quarter 2024 Financial Results on May 2, 2024
More ▼
Key statistics
On Wednesday, Geron Corp (0IV3:LSE) closed at 4.23, -20.77% below its 52-week high of 5.34, set on Jun 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 4.23 |
Low | 4.23 |
Bid | -- |
Offer | -- |
Previous close | 4.63 |
Average volume | 6.86k |
---|---|
Shares outstanding | 593.13m |
Free float | 592.61m |
P/E (TTM) | -- |
Market cap | 2.78bn USD |
EPS (TTM) | -0.3464 USD |
Data delayed at least 20 minutes, as of Jul 24 2024 03:42 BST.
More ▼